LifeSci Biotechnology Clinical Trials Index
Effective at the market close on November 26, 2024, LBPH will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights.
On October 14, 2026, LBPH announced it agreed to be acquired for $60.00/share in cash.